HealthEquity Inc. (NASDAQ:HQY) went up by 2.30% from its latest closing price compared to the recent 1-year high of $73.54. The company’s stock price has collected 1.23% of gains in the last five trading sessions. The Wall Street Journal reported on 12/07/21 that Tesla, Intel, Bitcoin: What to Watch in the Stock Market Today
Is It Worth Investing in HealthEquity Inc. (NASDAQ :HQY) Right Now?
Plus, the 36-month beta value for HQY is at 0.87. Opinions of the stock are interesting as 11 analysts out of 14 who provided ratings for HealthEquity Inc. declared the stock was a “buy,” while 1 rated the stock as “overweight,” 1 rated it as “hold,” and 1 as “sell.”
The average price from analysts is $79.07, which is $4.93 above the current price. HQY currently public float of 82.78M and currently shorts hold a 4.38% ratio of that float. Today, the average trading volume of HQY was 735.50K shares.
HQY’s Market Performance
HQY stocks went up by 1.23% for the week, with a monthly jump of 21.29% and a quarterly performance of 10.11%, while its annual performance rate touched 18.17%. The volatility ratio for the week stands at 3.46% while the volatility levels for the past 30 days are set at 3.96% for HealthEquity Inc. The simple moving average for the period of the last 20 days is 9.36% for HQY stocks with a simple moving average of 25.66% for the last 200 days.
Analysts’ Opinion of HQY
Many brokerage firms have already submitted their reports for HQY stocks, with KeyBanc Capital Markets repeating the rating for HQY by listing it as a “Overweight.” The predicted price for HQY in the upcoming period, according to KeyBanc Capital Markets is $85 based on the research report published on September 16th of the current year 2022.
Goldman, on the other hand, stated in their research note that they expect to see HQY reach a price target of $59. The rating they have provided for HQY stocks is “Sell” according to the report published on July 12th, 2022.
Wells Fargo gave a rating of “Overweight” to HQY, setting the target price at $95 in the report published on April 11th of the current year.
HQY Trading at 17.39% from the 50-Day Moving Average
After a stumble in the market that brought HQY to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -0.05% of loss for the given period.
Volatility was left at 3.96%, however, over the last 30 days, the volatility rate increased by 3.46%, as shares surge +18.55% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +23.55% upper at present.
During the last 5 trading sessions, HQY rose by +1.23%, which changed the moving average for the period of 200-days by +29.70% in comparison to the 20-day moving average, which settled at $67.79. In addition, HealthEquity Inc. saw 66.14% in overturn over a single year, with a tendency to cut further gains.
Reports are indicating that there were more than several insider trading activities at HQY starting from Sacks Ian, who sale 25,000 shares at the price of $72.28 back on Sep 20. After this action, Sacks Ian now owns 126,570 shares of HealthEquity Inc., valued at $1,806,925 using the latest closing price.
Bloomberg Edward, the CHIEF OPERATING OFFICER of HealthEquity Inc., sale 1,000 shares at $57.63 during a trade that took place back on Aug 01, which means that Bloomberg Edward is holding 59,850 shares at $57,630 based on the most recent closing price.
Stock Fundamentals for HQY
Current profitability levels for the company are sitting at:
- +5.36 for the present operating margin
- +45.06 for the gross margin
The net margin for HealthEquity Inc. stands at -5.85. Equity return is now at value -3.30, with -2.00 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 2.29.